Reduction in calcium excretion in women with breast cancer and bone metastases using the oral bisphosphonate pamidronate.

The bisphosphonate pamidronate (3 amino-1, 1-hydroxypropylidene bisphosphonate (APD), Ciba-Geigy) is a powerful inhibitor of osteoclast function and has been shown to significantly reduce osteolysis associated with bone metastases in breast cancer. Until recently, however, only an intravenous prepar...

Descripción completa

Detalles Bibliográficos
Autores principales: Dodwell, D. J., Howell, A., Ford, J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1990
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971333/
https://www.ncbi.nlm.nih.gov/pubmed/2297483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971333/
https://www.ncbi.nlm.nih.gov/pubmed/2297483

Ejemplares similares